Abstract:Objective This meta-analysis attempted to derive pooled estimates for the associations between various cardiovascular-renal disorders and the deletion/insertion (D/I) polymorphism of the angiotensin converting enzyme (ACE) gene.Methods Case-control studies were combined, using the Mantel-Haenszel approach. Joint P values for continuous variables were calculated by Stouffer's method. Continuous measurements reported in different units were expressed on a percentage scale using the within-study mean of the II genotype as the denominator.Results The computerized database used for this analysis included 145 reports with an overall sample size of 49 959 subjects. Overall, possession of the D allele was associated with an increased risk of atherosclerotic and renal microvascular complications. In comparison with the II reference group, the excess risk in DD homozygotes (P < 0.001) was 32% for coronary heart disease (CHD; 30 studies), 45% for myocardial infarction (20 studies), 94% for stroke (five studies) and 56% for diabetic nephropathy (11 studies). The corresponding risk in DI heterozygotes amounted to 11% (P = 0.02), 13% (P = 0.02), 22% (P = 0.10) and 40% (P < 0.001), respectively. Hypertension (23 studies), left ventricular hypertrophy (five studies), hypertrophic or dilated cardiomyopathy (eight studies) and diabetic retinopathy (two studies) were not related to the DI polymorphism. Publication bias was observed for CHD, myocardial infarction and microvascular nephropathy, but not hypertension. In studies with DNA amplification in the presence of insertion-specific primers, the risk associated with the DD genotype increased to 150% [95% confidence interval (CI) 76-256; four studies] for diabetic nephropathy, but decreased to 12% (95% CI -3 to 28; seven studies) for CHD and 14% (95% CI -6 to 37; four studies) for myocardial infarction. On the other hand, the pooled odds ratios did not materially change if the metaanalysis was limited to articles published in journals with an impact factor of at least 4. Furthermore, compared with the II control group, the circulating ACE levels (29 studies) were raised 58 and 31% (P < 0.001) in DD and DI subjects, respectively. In contrast, plasma renin (10 studies), systolic and diastolic blood pressure (46 studies) and body mass index (30 studies) were not associated with the D allele.Conclusion The D allele is not associated with hypertension, but behaves as a marker of atherosclerotic cardiovascular complications and diabetic nephropathy. These associations do not necessarily imply a causal relationship and may have been inflated by publication bias. Nevertheless, their possible therapeutic implications may be subject to further investigation in prospective (intervention) studies. (C) Rapid Science Publishers ISSN 0263-6352.

Angiotensin Converting Enzyme Gene Polymorphism and its Association with Hypertension in South Indian Population

Coronary heart disease, hypertension, and angiotensinogen gene variants in indian opulation

ANGIOTENSIN-CONVERTING ENZYME GENE POLYMORPHISM IN UNTREATED ESSENTIAL HYPERTENSION AND RESPONSE TO ANGIOTENSIN CONVERTING ENZYME INHIBITORS

Polymorphism of angiotensin converting enzyme in Han populations and its relevance to the severity of coronary atherosclerosis]

The Deletion/insertion Polymorphism of the Angiotensin Converting Enzyme Gene and Cardiovascular-Renal Risk.

The frequency of the ACE I/D polymorphism in South America: a systematic review and meta-analysis

Genetic Polymorphisms in the Renin–angiotensin System: Relevance for Susceptibility to Cardiovascular Disease

mRNA expression profile in peripheral blood mononuclear cells based on ADRB1 Ser49Gly and Arg389Gly polymorphisms in essential hypertension — a case-control pilot investigation in South Indian population

Angiotensin-Converting Enzyme I/D Polymorphism is Associated with Copd Risk in Asian Population: Evidence from A Meta-Analysis

Insertion/deletion Polymorphism of the Angiotensin I—converting Enzyme Gene in Patients with Hypertension, Non—insulin-Dependent Diabetes Mellitus, and Coronary Heart Disease in Taiwan

Relationship between polymorphisms in RAS and blood pressure-lowering response to irbesartan in hypertensive patients

Angiotensin Converting Enzyme Gene Insertion/Deletion Polymorphism Is Not Responsible for Antihypertensive Therapy Induced New Onset of Type 2 Diabetes in Essential Hypertension

AGT, CYP11B2 & ADRB2 gene polymorphism & essential hypertension (HT): A meta-analysis

Association of Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism with the Risk of Atherosclerosis.

ACE gene I/D polymorphism and arterial hypertension in patients with COPD

Polymorphism of Angiotensin-Converting Enzyme Gene and Type 2 Diabetes

Association Study of Angiotensin Converting Enzyme Polymorphism with Myocardial Infarction in Chinese

Association of Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism with the Risk of Atherosclerosis

Review: Association Between Angiotensin Converting Enzyme G2350A Polymorphism and Hypertension Risk: a Meta-Analysis

Antihypertensive treatment modulates the association between the D/I ACE gene polymorphism and left ventricular hypertrophy: a meta-analysis

Genetic Factors Contributing to the Pathogenesis of Essential Hypertension in Two African Populations